PDI-192
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PDI-192, covering 2014-05-29 to 2014-05-29. Get the full timeline:
Most recent: Clinical Trial Update: An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis [Phase 2]